Correlation Between Bolt Biotherapeutics and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bolt Biotherapeutics and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bolt Biotherapeutics and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bolt Biotherapeutics and Lyra Therapeutics, you can compare the effects of market volatilities on Bolt Biotherapeutics and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bolt Biotherapeutics with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bolt Biotherapeutics and Lyra Therapeutics.
Diversification Opportunities for Bolt Biotherapeutics and Lyra Therapeutics
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bolt and Lyra is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Bolt Biotherapeutics and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Bolt Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bolt Biotherapeutics are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Bolt Biotherapeutics i.e., Bolt Biotherapeutics and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Bolt Biotherapeutics and Lyra Therapeutics
Given the investment horizon of 90 days Bolt Biotherapeutics is expected to generate 0.31 times more return on investment than Lyra Therapeutics. However, Bolt Biotherapeutics is 3.19 times less risky than Lyra Therapeutics. It trades about -0.2 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 65.00 in Bolt Biotherapeutics on August 24, 2024 and sell it today you would lose (8.00) from holding Bolt Biotherapeutics or give up 12.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bolt Biotherapeutics vs. Lyra Therapeutics
Performance |
| Timeline |
| Bolt Biotherapeutics |
| Lyra Therapeutics |
Bolt Biotherapeutics and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bolt Biotherapeutics and Lyra Therapeutics
The main advantage of trading using opposite Bolt Biotherapeutics and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bolt Biotherapeutics position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Bolt Biotherapeutics vs. Lyra Therapeutics | Bolt Biotherapeutics vs. Hookipa Pharma | Bolt Biotherapeutics vs. Cingulate Warrants | Bolt Biotherapeutics vs. SAB Biotherapeutics |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |